Upstream Bio, Inc.
Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)โข Click on a phase to view related trials
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Other: Placebo
- First Posted Date
- 2025-05-20
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Upstream Bio Inc.
- Target Recruit Count
- 666
- Registration Number
- NCT06981078
- Locations
- ๐บ๐ธ
Qway Research, LLC, Hialeah, Florida, United States
๐บ๐ธVelocity Clinical Research, Spartanburg - Pulmonology, Spartanburg, South Carolina, United States
๐บ๐ธVelocity Clinical Research- Union, Union, South Carolina, United States
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-09-19
- Lead Sponsor
- Upstream Bio Inc.
- Target Recruit Count
- 436
- Registration Number
- NCT06966479
- Locations
- ๐บ๐ธ
California Medical Research Associates Inc., Northridge, California, United States
๐บ๐ธAllianz Research Institute, Westminster, California, United States
๐บ๐ธPhoenix Medical Research, Miami, Florida, United States
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)
- Conditions
- Severe Asthma
- Interventions
- Drug: Verekitug (UPB-101)Drug: Placebo
- First Posted Date
- 2024-01-09
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Upstream Bio Inc.
- Target Recruit Count
- 479
- Registration Number
- NCT06196879
- Locations
- ๐บ๐ธ
AllerVie Clinical Research, Birmingham, Alabama, United States
๐บ๐ธKern Research, Inc., Bakersfield, California, United States
๐บ๐ธVelocity Clinical Research - Lafayette LA, Los Angeles, California, United States
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps
- Conditions
- Chronic Rhinosinusitis With Nasal Polyps
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Upstream Bio Inc.
- Target Recruit Count
- 45
- Registration Number
- 2023-508231-31-00
- Locations
- ๐จ๐ฟ
ORL ambulance MUDr. Pavel Navratil, Olomouc, Czechia
๐จ๐ฟFakultni Nemocnice Hradec Kralove, Novy Hradec Kralove, Czechia
๐ฉ๐ชUniversitaetsklinikum Tuebingen AรถR, Tuebingen, Germany
Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Upstream Bio Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05653479
- Locations
- ๐ฌ๐ง
Richmond Pharmacology, London, United Kingdom
- Prev
- 1
- 2
- Next